Technical Analysis for JNJ - Johnson & Johnson

Grade Last Price % Change Price Change
grade D 127.7 -6.22% -8.47
JNJ closed down 6.22 percent on Friday, October 18, 2019, on 3.44 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical JNJ trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Gapped Down Weakness 0.00%

Older signals for JNJ ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Health Pain Infectious Diseases Retail Outlets Infection Pharmacology Healthcare Industry Pain Management Cardiovascular Disease Diagnostic Products Energy Products General Surgery Thrombosis Infection Prevention Products Insulin Delivery Johnson & Johnson
Is JNJ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 148.99
52 Week Low 121.0
Average Volume 7,507,371
200-Day Moving Average 134.5914
50-Day Moving Average 130.6132
20-Day Moving Average 131.2565
10-Day Moving Average 131.721
Average True Range 2.8119
ADX 15.49
+DI 28.3582
-DI 33.9781
Chandelier Exit (Long, 3 ATRs ) 129.0543
Chandelier Exit (Short, 3 ATRs ) 135.1357
Upper Bollinger Band 135.5576
Lower Bollinger Band 126.9554
Percent B (%b) 0.09
BandWidth 6.553733
MACD Line 0.4409
MACD Signal Line 0.3879
MACD Histogram 0.053
Fundamentals Value
Market Cap 342.75 Billion
Num Shares 2.68 Billion
EPS 5.75
Price-to-Earnings (P/E) Ratio 22.21
Price-to-Sales 5.12
Price-to-Book 5.29
PEG Ratio 2.79
Dividend 3.36
Dividend Yield 2.63%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 137.74
Resistance 3 (R3) 138.85 136.62 136.06
Resistance 2 (R2) 136.62 134.06 136.06 135.50
Resistance 1 (R1) 132.16 132.49 131.05 131.05 134.95
Pivot Point 129.93 129.93 129.37 129.37 129.93
Support 1 (S1) 125.47 127.37 124.36 124.36 120.45
Support 2 (S2) 123.24 125.80 122.68 119.90
Support 3 (S3) 118.78 123.24 119.34
Support 4 (S4) 117.67